NCT03797625 2025-07-23Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasFudan UniversityPhase 2 Completed52 enrolled
NCT02350517 2023-02-16Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal CancerSun Yat-sen UniversityPhase 2 Completed52 enrolled